Antigen-Induced Mixed and Separated Inflammation in Murine Upper and Lower Airways  by Saeki, Mayumi et al.
Allergology International Vol 63, Suppl 1, 2014 www.jsaweb.jp 59
Dear Editor
Antigen-Induced Mixed and Separated
Inflammation in Murine Upper
and Lower Airways
Allergic rhinitis (AR) and bronchial asthma (BA)
have been recognized as manifestations of a single
entity allergic respiratory disease. It has been shown
that many patients with BA also suffer nasal symp-
toms, even though not all the asthmatic patients de-
velop AR.1 In addition, AR is regarded as a risk factor
for the development of BA. Previous studies have re-
ported that AR patients show increased onset of bron-
chial hyperresponsiveness (BHR) even without any
clinical evidence of BA.2 Therefore, in order to inves-
tigate the relationship between AR and BA, it is im-
portant to compare the inflammatory responses de-
veloped in the upper and lower airways. However,
analysis models capable of separately inducing aller-
gic responses in the upper and lower airways have
scarcely been reported.
Numerous murine models of allergic airway inflam-
mation have been used to study the pathogenesis of
AR and BA.3,4 In most of them, antigen was chal-
lenged via the upper airway by provocation with a
nebulized antigen or by intranasal (i.n.) instillation of
an aqueous antigen.3,5 Then, inflammatory responses
were evidently observed in the lower airways. How-
ever, even though challenged antigen exactly passes
through the nasal cavity, most of these models have
not investigated the nasal responses, and therefore it
has not been fully clarified whether nasal and bron-
choalveolar inflammation is occurred at the same
time after antigen challenge via the nasal route.
In order to develop murine models individually dis-
playing upper and lower airway inflammation, we
compared the nasal and bronchoalveolar responses in
ovalbumin (OVA)-immunized mice upon three differ-
ent antigen challenge procedures, high-volume (a sin-
gle shot of 25 μL antigen) i.n. challenge (INHV),
low-volume (four shots of 5 μL antigen) i.n. challenge
(INLV), and intratracheal (i.t.) challenge (IT) (Sup-
plementary Fig. 1 and SUPPLEMENTARY METH-
ODS).
OVA-IT induced infiltration of inflammatory cells
into the lower airways without affecting the nose.
Thus, large numbers of eosinophils and neutrophils
were recovered in bronchoalveolar lavage fluid
(BALF) of OVA-IT mice, though only the change in
eosinophils was statistically significant (Fig. 1a, b).
On the other hand, the nasal lavage fluid (NALF)
cells were hardly observed in OVA- or saline-IT mice
(Fig. 1c, d).
On the contrary, OVA-INLV caused infiltration of
inflammatory cells into the nasal cavity without affect-
ing the lower airway. The numbers of eosinophils and
neutrophils in NALF significantly increased in re-
sponse to INLV with OVA (Fig. 1c, d), though the
BALF cells were hardly observed in OVA- or saline-
INLV mice (Fig. 1a, b).
Upon OVA-INHV, inflammatory responses were
induced in both the lungs and nasal cavity. The num-
bers of eosinophils and neutrophils in BALF (Fig. 1a,
b) as well as NALF (Fig. 1c, d) clearly increased,
though the change in the NALF cells was not statisti-
cally significant.
These inflammatory features were confirmed by
upper and lower airway-specific pathophysiological
responses. As shown in Figure 1e, the sneezing re-
sponse, a common symptom of AR, was significantly
induced in OVA-INLV mice, in comparison with
saline-challenged control mice. The same level sneez-
ing response was also observed in OVA-INHV mice,
though it was not statistically significant in compari-
son with saline-INHV mice. This might be because,
at least in part, a relatively large number of sneezing
was induced by INHV with saline. These findings
suggest that antigen challenge through the nasal cav-
ity exactly induces the nasal response in immunized
mice even though instillation of high-volume aqueous
solution into the nose also triggers non-specific
sneezing response. In contrast, sneezing was hardly
observed in OVA- or saline-IT mice (Fig. 1e).
On the other hand, the bronchial responsiveness of
OVA-IT and OVA-INHV but not OVA-INLV mice
was significantly augmented in comparison with that
of saline-challenged mice (Fig. 1f).
Consequently, in our models, OVA-IT enabled to
induce lower airway-specific inflammatory responses.
In contrast, upper airway-specific responses and si-
multaneous upper and lower airway responses were
successfully induced by OVA-INLV and -INHV, re-
spectively.
Recently, the relationship between allergic upper
and lower airway diseases has become widely recog-
nized. Indeed, several mechanisms of lower airway
dysfunction in patients with AR such as altered
breathing pattern have been suggested. 6,7 These
clinical observations seem to be reproduced in our
mouse model in which both upper and lower airway
responses were obtained by INHV procedure.
On the other hand, in order to investigate the
mechanisms of allergic upper and lower airway in-
flammation distinctively, several attempts to develop
corresponding murine models have been made so
far. Prior to the successful establishment of separated
upper and lower airway inflammation models in our
present study, Li et al. have also tried to create such
models. 8 Even though certain levels of upper and
lower airway-specific inflammation were observed in
their models, they rinsed the nasal cavity of mice
with saline after the nasal antigen application in the
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Fig.　1　Intranasal or intratracheal antigen challenge-induced infl ammatory responses. The number of 
eosinophils and neutrophils in BALF (a and b) and NALF (c and d), sneezing response (e) and bronchial 
responsiveness (f) in IN/HV, IN/LV, and IT mice were evaluated. Detailed protocols are described in the 
Supplementary Materials. *p < 0.05, **p < 0.01 (n = 3-7). BALF, bronchoalveolar lavage fl uid; HV, high-
volume challenge; IN, intranasal; IT, intratracheal challenge; LV, low-volume challenge; Mch, methacho-
line; NALF, nasal lavage fl uid; OVA, ovalbumin; Rrs, respiratory system resistance.
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case of antigen challenge to the lower airways. In our
present study, lower airway-specific inflammation was
induced by the direct i. t. administration of antigen.
Therefore, the experimental system we used for in-
ducing bronchoalveolar responses is most likely to
less physical irritating to the nasal cavity and more
selective to the lower airways than that used by Li et
al.
In apparent contradiction with our findings that up-
per airway-specific responses without affecting bron-
chial responsiveness were obtained in INLV experi-
ment, Hens et al. reported that a selective nasal anti-
gen provocation induced significant BHR in mice. 9
The reason for the discrepancy is unclear, though
mice were challenged with inhaled antigen for 8 con-
secutive days before the nose-specific antigen provo-
cation in their models. Therefore, the lung function
might already be affected during the antigen inhala-
tion period. In order to elucidate the exact relation-
ship between allergic upper and lower airway dis-
eases, it may be helpful to study whether long-term
INLV in our experimental system affects lower air-
way function.
In conclusion, we developed the comparative
murine models of mixed and separated upper and
lower airway inflammation by employing i.n. and i.t.
challenge procedures. They may be useful for under-
standing the mechanisms, progression and relation-
ship of allergic airway diseases, such as AR and BA.
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